loadpatents
name:-0.017537117004395
name:-0.0053231716156006
name:-0.0055520534515381
Nichols; Gwen Patent Filings

Nichols; Gwen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nichols; Gwen.The latest application filed is for "novel combination treatment for acute myeloid leukemia (aml)".

Company Profile
4.5.18
  • Nichols; Gwen - New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for administration
Grant 11,382,892 - Higgins , et al. July 12, 2
2022-07-12
Novel Combination Treatment For Acute Myeloid Leukemia (aml)
App 20220031726 - Higgins; Brian ;   et al.
2022-02-03
Method For Administration
App 20210069149 - Glenn; Kellie ;   et al.
2021-03-11
Novel Combination Treatment For Acute Myeloid Leukemia (aml)
App 20200253999 - Kind Code
2020-08-13
Method For Administration
App 20200085788 - Higgins; Brian ;   et al.
2020-03-19
Method For Administration
App 20190328708 - Glenn; Kelli ;   et al.
2019-10-31
Combination treatment for acute myeloid leukemia (AML)
Grant 9,956,243 - Higgins , et al. May 1, 2
2018-05-01
Methods For Personalizing Patient Cancer Therapy With An Mdm2 Antagonist
App 20170227544 - Blotner; Steven D. ;   et al.
2017-08-10
MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonist
Grant 9,657,351 - Zhong , et al. May 23, 2
2017-05-23
Combination therapy for proliferative disorders
Grant 9,486,445 - Higgins , et al. November 8, 2
2016-11-08
Novel Combination Treatment For Acute Myeloid Leukemia (aml)
App 20160303158 - Higgins; Brian ;   et al.
2016-10-20
Combination Of Ro5503781, Capecitabine And Oxaliplantin For Cancer Therapy
App 20160129034 - Higgins; Brian ;   et al.
2016-05-12
Combination Of Ro5503781 And Capecitabine For Cancer Therapy
App 20160129033 - Higgins; Brian ;   et al.
2016-05-12
Combination Therapy For Proliferative Disorders
App 20160051525 - HIGGINS; Brian ;   et al.
2016-02-25
Combination therapy for proliferative disorders
Grant 9,216,170 - Higgins , et al. December 22, 2
2015-12-22
Mrna-based Gene Expression For Personalizing Patient Cancer Therapy With An Mdm2 Antagonist
App 20150211073 - Zhong; Hua ;   et al.
2015-07-30
Method For Administration
App 20150202182 - Higgins; Brian ;   et al.
2015-07-23
Novel Combination Treatment For Acute Myeloid Leukemia (aml)
App 20150157603 - Higgins; Brian ;   et al.
2015-06-11
Method For Administration
App 20150126575 - Glenn; Kelli ;   et al.
2015-05-07
Method For Administration
App 20140200255 - HIGGINS; BRIAN ;   et al.
2014-07-17
Combination Therapy For Proliferative Disorders
App 20130245039 - Higgins; Brian ;   et al.
2013-09-19
Method For Administration
App 20130245089 - Glenn; Kelli ;   et al.
2013-09-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed